HOME >> MEDICINE >> NEWS
GSK announces launch of largest ever Phase III trial in lung cancer treatment

Chicago - June 5th, 2007 GlaxoSmithKline (GSK) today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC). These data were presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, [Abstract No: 7554]. Final trial analysis showed a 27% reduction in the relative risk of cancer recurrence following surgery in patients treated with the MAGE-A3 ASCI, compared to placebo.

Final results from this trial confirm the positive interim results released last year at ASCO 2006, and support expanded testing of this novel cancer immunotherapy, said Paul A. Bunn Jr., M.D., James Dudley Endowed Professor of Oncology, Professor of Medicine and Director of the University of Colorado Cancer Center, Aurora, Colorado. This approach represents a potentially momentous shift in the cancer treatment paradigm. I believe we have only just scratched the surface of what is possible and look forward to seeing the results of the Phase III trial in due course.

Based on these encouraging data, GSK also announced today the opening of patient recruitment to the randomized and controlled Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3 positive patients with completely resected stage IB, II or IIIA NSCLC.

GSKs ASCIs aim to stimulate the patients own immune response to identify and attack cancer cells in a highly specific manner. This novel cancer immunotherapy is developed using tumor specific antigens, delivered as highly purified recombinant proteins, and GSKs own proprietary Adjuvant Systems, which are specifically designed to enhance ASCIs anti-tumor activity

Phase
'"/>

Contact: Andrea Long
andreal@wagged.com
202-326-0791
GlaxoSmithKline Biologicals
5-Jun-2007


Page: 1 2 3

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. AstraZeneca announces SYMBICORT is now available in the US
3. Weill Cornell Medical College announces gifts totaling $400M
4. Elsevier announces launch of Brain Stimulation
5. NSW Premier announces $15M for childrens cancer research
6. National Inventors Hall of Fame announces 2007 inductees
7. Emory University announces new Global Health Institute
8. BioMed Central announces Journal of Medical Case Reports
9. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
10. Wiley announces partnership with NASPGHAN and AASLD
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2019)... ... 2019 , ... The number of public health departments around ... performance continues to climb. Today, the Public Health Accreditation Board (PHAB) ... health departments. With this week's accreditation decisions, tens of thousands more people can ...
(Date:6/19/2019)... YORK (PRWEB) , ... June 19, 2019 , ... Expanding ... Children’s Causes,” the American Foundation of Savoy Orders raised thousands for Caterina’s Club during ... Angeles on April 6, 2019. This year, $100,000 was donated for the Southern ...
(Date:6/18/2019)... ... June 18, 2019 , ... ... added to its joint conference with the Houston Healthcare HR Association (HHHRA - ... the conference, HR Maximizer welcomes Staywell, Walden University, PageUp, CRC, Alliance Work Partners ...
(Date:6/16/2019)... ... June 15, 2019 , ... Convoy of Hope continues to celebrate its 25th ... those in need around the world. To date, Convoy has worked with more than ... would not be possible without the dedication and generosity of churches, organizations, and individuals ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
Breaking Medicine News(10 mins):
(Date:6/19/2019)... GREENBELT, Md. (PRWEB) , ... June 19, 2019 , ... ... Glassdoor Employees’ Choice Award honoring the Top CEOs in 2019 . ... award recognizing the Top CEOs, which highlights world-class leaders that employees love working for ...
(Date:6/19/2019)... ... ... A new survey by The Senior Citizens League (TSCL) indicates that ... If that doesn’t sound like enough of a challenge, at a time when the ... $1,000 per month or more. The same survey also found that, of those ...
(Date:6/18/2019)... ... June 18, 2019 , ... ... facilities at 11500 W Olympic Blvd Suite 350 Los Angeles, CA, 90064, bringing ... research-backed methodologies. , MY Education Guru has created individual programs to assist ...
Breaking Medicine Technology:
Cached News: